1Autophagy regulation combined with stem cell therapy for treatment of spinal cord injuryYao Shen，Yi-Piao Wang，Xin Cheng，Xuesong Yang，Guang WangReviews1629-1636
2FcRn inhibitors: a novel option for the treatment of myasthenia gravisLi-Na Zhu，Hai-Man Hou，Sai Wang，Shuang Zhang，Ge-Ge Wang，Zi-Yan Guo，Jun WuReviews1637-1644
3Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challengesRenata Guedes de Jesus Gon?alves，Juliana Ferreira Vasques，Almir Jord?o da Silva-Junior，Fernanda Gubert，Rosalia Mendez-OteroReviews1645-1651
4The transient receptor potential melastatin 2: a new therapeutical target for Parkinson's disease?Ana Flávia F.Ferreira，Luiz Roberto G.BrittoReviews1652-1656
5Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injuryYu-Yan Liu，Yun Li，Lu Wang，Yan Zhao，Rui Yuan，Meng-Meng Yang，Ying Chen，Hao Zhang，Fei-Hu Zhou，Zhi-Rong Qian，Hong-Jun KangReviews1657-1665
6The role of monocytes in optic nerve injuryXiangxiang Liu，Yuan Liu，Mohamed M.Khodeiry，Richard K.LeeReviews1666-1671
7Immortalized hippocampal astrocytes from 3xTg-AD mice, a new model to study disease-related astrocytic dysfunction: a comparative reviewLaura Tapella，Giulia Dematteis，Armando A Genazzani，Massimiliano De Paola，Dmitry LimReviews1672-1678
8Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trialsBruno P.Imbimbo，Viviana Triaca，Camillo Imbimbo，Robert NisticòReviews1679-1683
9The role of purinergic receptors in neural repair and regeneration after spinal cord injuryRui-Dong Cheng，Wen Ren，Ben-Yan Luo，Xiang-Ming YeReviews1684-1690
10Role of vascular endothelial growth factor as a critical neurotrophic factor for the survival and physiology of motoneuronsPaula M.Calvo，Rosendo G.Hernández，Rosa R.de la Cruz，Angel M.PastorReviews1691-1697
11Prenatal and postnatal drug exposure: focus on persistent central effectsGiulia Costa，Alexia E.PollackReviews1697-1702
12Overcoming axon regeneration failure and psychopathology: how may gabapentinoids help boost CNS repair?Haven I.Rodocker，Andrea TedeschiPerspectives1703-1704
13Neuroplastin in Ca2+ signal regulationand plasticity of glutamatergic synapsesAyse Malci，Xiao Lin，Yun Stone Shi，Rodrigo Herrera-MolinaPerspectives1705-1706
14Gut microbiota neurotransmitters: influence on risk and outcome of ischemic strokeRyszard Pluta，S?awomir JanuszewskiPerspectives1707-1708
15In vitro microglia models: the era of engineered cell microenvironmentsAhmed Sharaf，Raissa Timmerman，Jeffrey Bajramovic，Angelo AccardoPerspectives1709-1710
16Augmentation of transforminggrowth factor-β signaling for the treatment of neurological disordersJian LuoPerspectives1711-1712
17Therapeutic potential of lysosomal cathepsins for neurodegenerative diseasesSusy Prieto Huarcaya，Friederike ZunkePerspectives1713-1714
18Neurovascular unit permeability in neuroinflammatory diseases: a common pathologic and therapeutic target?Molly Monsour，Cesar V.BorlonganPerspectives1715-1716
19Brain network correlates of epilepsy occurrence in multiple sclerosis and neuroinflammationDumitru Ciolac，Gabriel Gonzalez-Escamilla，Yaroslav Winter，Vinzenz Fleischer，Matthias Grothe，Sergiu GroppaPerspectives1717-1718
20Oxidative stress in N88S seipinopathy: novel insights into the mechanisms of neurodegeneration and therapeutic avenuesVítor Costa，Vitor TeixeiraPerspectives1719-1720
